Tips from Other Journals

Plain Ophthalmic Tetracaine vs. Buffered Preparation


Am Fam Physician. 2004 Feb 15;69(4):962.

Examination of patients with eye problems often requires topical ophthalmic anesthesia. Tetracaine hydrochloride solution commonly is used because it easily penetrates all three layers of the cornea. Instillation of ophthalmic analgesics can be painful; some experts think that the acidity of the solution causes corneal swelling and edema, resulting in pain. Tetracaine hydrochloride 0.5 percent ophthalmic solution has an acidic pH level of 4.54. Bicarbonate has been used as a buffer to decrease the pain of local anesthetics and ophthalmic solutions. Weaver and associates compared pain on instillation of plain tetracaine hydrochloride ophthalmic solution with pain caused by a solution buffered with sodium bicarbonate to a pH level of 7.4.

Using a prospective, randomized, double-blinded, crossover research design, volunteers 18 years and older received two drops of 0.5 percent tetracaine hydrochloride or two drops of 0.5 percent tetracaine hydrochloride buffered with sodium bicarbonate to a pH level of 7.4. After at least seven days, each participant crossed over to receive a similar dose of the other study drug. Pain severity on instillation was measured using a 100-mm visual analog scale (VAS). Assessments were done at one and five minutes after instillation.

Fifty-one (85 percent) of the 60 subjects reported pain immediately after administration of buffered tetracaine. Fewer, but not significantly fewer, patients reported pain immediately following administration of the plain tetracaine. Based on specific pain scores at all measurements, the VAS for buffered tetracaine was significantly higher than that for the plain solution. The results did not vary by the patients' gender or use of contact lenses, and no adverse events were documented.

The authors conclude that a buffered solution for ophthalmic anesthesia was more painful than a plain solution. Possible reasons for the problem with buffered solutions could be the presence of a precipitate or the increased penetrability of a pH-adjusted ophthalmic solution that may result in an increased perception of pain. Because these results were noted in normal control patients, they should be confirmed in patients with painful eye conditions.

Weaver CS, et al. A prospective, randomized, double-blind comparison of buffered versus plain tetracaine in reducing the pain of topical ophthalmic anesthesia. Ann Emerg Med. June 2003;41:827–31.



Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


May 2022

Access the latest issue of American Family Physician

Read the Issue

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article